Editorial: coeliac disease-it's a family affair

Affiliations

Editorial

Amelie Therrien et al. Aliment Pharmacol Ther. 2021 Oct.

. 2021 Oct;54(7):967-968.

doi: 10.1111/apt.16552.

¹ The Celiac Center, Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

No abstract available

Comment in

Editorial: coeliac disease-it's a family affair. Authors' reply.
Paavola S, Kaukinen K, Kurppa K. Paavola S, et al. Aliment Pharmacol Ther. 2021 Oct;54(7):969. doi: 10.1111/apt.16584. Aliment Pharmacol Ther. 2021. PMID: 34506653 No abstract available.

Presence of high-risk HLA genotype is the most important individual risk factor for coeliac disease among at-risk relatives.
Paavola S, Lindfors K, Kivelä L, Cerqueira J, Huhtala H, Saavalainen P, Tauschi R, Kaukinen K, Kurppa K. Paavola S, et al. Aliment Pharmacol Ther. 2021 Sep;54(6):805-813. doi: 10.1111/apt.16534. Epub 2021 Jul 18. Aliment Pharmacol Ther. 2021. PMID: 34278595

1. Sharma A, Liu X, Hadley D, et al. Identification of non-HLA genes associated with celiac disease and country-specific differences in a large, international pediatric cohort. PLoS One. 2016;11:e0152476.
1. Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA; American College of Gastroenterology. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656-676; quiz 677.
1. Al-Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019;7:583-613.
1. Singh P, Arora S, Lal S, Strand TA, Makharia GK. Risk of celiac disease in the first- and second-degree relatives of patients with celiac disease: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110:1539-1548.
1. Faye AS, Polubriaginof F, Green PHR, Vawdrey DK, Tatonetti N, Lebwohl B. Low rates of screening for celiac disease among family members. Clin Gastroenterol Hepatol. 2019;17:463-468.